Implantable Medical Devices Market Is Expected to Reach a Valuation of US$ 49.8 Billion by the End of 2024
The global implantable medical devices market features a largely consolidated competitive landscape, with the top five companies accounting for a share of more than 50% in 2015, reports TMR in a recent report. These companies, including Zimmer Biomet, Johnson & Johnson, Stryker Corporation, Medtronic plc, Institut Straumann AG, hold sway owing to innovation, rapid introduction of newer and more effective product varieties, and presence across several key regional markets. Being a technology- and research-intensive field, governed by stringent approval regulations,...
View full press release